Direct Data Capture (DDC) is one of the four types of eSource (see previous post), and is often what people first think of as eSource. Direct data capture is the process of entering data into the eCRF contemporaneously, rather than transcribing from other sources such as paper or site EHR systems. Some technology providers believe that EDC systems can be used as eSource, where the web based EDC system is carried around on a laptop, or potentially a tablet, and data is entered directly into this system.
eSource means different things to different people. You may have never even heard of it, so this is the first in a series of posts which aim to unlock what eSource is. When I ask “What does eSource mean to you?”, I receive many different answers, and quite often they weren’t what I had expected. Perhaps we should start by reminding ourselves of the current method for collecting and managing data in clinical trials.
Cmed Technology announces 20 years of clinical trial software provision and hosting with zero downtime. Encapsia is Cmed’s clinical data suite designed around a unified clinical database with user-centric apps to support all trial processes and a full cloud architecture. The inherent flexibility of this structure means mid study protocol amendments or technical system updates can be made with no disruption for users. In this respect, much of the knowledge and experience of Cmed’s previous technology platform, Timaeus, was applied to encapsia.
What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both Encapsia and our industry. Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like Encapsia.
It is now much easier for clinical trial sites to manage subject data as well as randomization, inventory management and drug dispensation. These processes can now be performed in real time using the single interface and unified database of Encapsia, the clinical data suite developed by Cmed’s technology division. The breakthrough announced today has been made possible by a deep “hyper integration” between Encapsia with leading-edge technology platforms PULSE and DRIVE from endpoint Clinical.
A recent survey on the challenges and opportunities in clinical data management by Pharma Intelligence reveals the most pressing issues today include the absence of real-time access to clinical trial data and that 90% of the effort involved in aggregating, cleaning and transforming data is manual. Moreover, over 80% of the respondents considered that incomplete and inconsistent data represents the top issue for regulatory compliance. Lastly, perhaps one of the most important findings was that eSource data is the future - finding ways to clean and manage new forms of data will be the next step in the progress of clinical trials.